We are live on ! Find out more
INMB icon

INmune Bio
INMB

36 hedge funds and large institutions have $17.4M invested in INmune Bio in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

56% more call options, than puts

Call options by funds: $645K | Put options by funds: $413K

6% more funds holding

Funds holding: 34 → 36 (+2)

0% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 10

1.64% less ownership

Funds ownership: 12.86% → 11.23% (-1.6%)

9% less capital invested

Capital invested by funds: $19.1M → $17.4M (-$1.72M)

Holders
36
Holders Change
+2
Holders Change %
+5.88%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
10
Reduced
10
Closed
3
Calls
$645K
Puts
$413K
Net Calls
+$232K
Net Calls Change
+$288K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$239K
2
SC
Sepio Capital
Utah
+$164K
3
Deutsche Bank
Deutsche Bank
Germany
+$112K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$79.6K
5
Group One Trading
Group One Trading
Illinois
+$70.8K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$686K
2
Marshall Wace
Marshall Wace
United Kingdom
-$568K
3
ACM
ACT Capital Management
Pennsylvania
-$521K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$387K
5
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
-$368K
Name Holding Trade Value Shares
Change 		Change in
Stake
VNA
26
Valley National Advisers
Pennsylvania
$10K – – –
CCM
27
Covington Capital Management
California
$9K – – –
PNC Financial Services Group
28
PNC Financial Services Group
Pennsylvania
$8K +$6.1K +820 New
ADL
29
Asset Dedication LLC
California
$7K – – –
HNWAG
30
High Net Worth Advisory Group
Florida
$4K – – –
FDCDDQ
31
Federation des caisses Desjardins du Quebec
Quebec, Canada
$3.54K – – –
FIA
32
FNY Investment Advisers
New York
$2K -$1.86K -250 -50%
CAPTRUST Financial Advisors
33
CAPTRUST Financial Advisors
North Carolina
$2K – – –
CFN
34
Cordasco Financial Network
Florida
$1K – – –
IA
35
IFP Advisors
Florida
$1K – – –
WIM
36
Westside Investment Management
California
$266 +$27.9K +3,750 +14%
Marshall Wace
37
Marshall Wace
United Kingdom
– -$568K -67,373 Closed
Susquehanna International Group
38
Susquehanna International Group
Pennsylvania
– -$387K -52,042 Closed
AA
39
ALPS Advisors
Colorado
– -$155K -18,363 Closed
1
2

INMB Hedge Fund Activity: Q2 2022 in Review

36 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in INmune Bio (INMB) for Q2 2022, worth a combined $17.4M — down 9% from $19.1M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new INMB positions and 3 closed out — a net gain of 2 holders — while 10 added to existing stakes and 10 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $239K. The largest seller was Morgan Stanley, cutting an estimated $686K.

  • 36 institutional investors held INmune Bio (INMB) as of Q2 2022, up from 34 in Q1 2022.
  • Funds reported $17.4M of INmune Bio stock for Q2 2022, down 9% quarter-over-quarter.
  • 5 funds opened new INmune Bio positions in Q2 2022 and 3 closed out, a net change of +2 holders.
  • The largest INmune Bio buyer in Q2 2022 was Renaissance Technologies, an estimated $239K added.
  • The largest INmune Bio seller in Q2 2022 was Morgan Stanley, an estimated $686K sold.

Based on aggregated 13F filings for Q2 2022.